Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Lu

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Chinese Medical Journal|September 1, 1994
Smooth muscle tumors of the gastrointestinal tract. Expression of ras P21 oncogene product and the association with clinicopathologyJ H Cai, Y K Jiang, Y Y Zhang, et al.
Zhonghua Yi Xue Za Zhi|February 13, 2026
[Clinical efficacy analysis of globus pallidus internus deep brain stimulation for the treatment of tardive dyskinesia in 5 cases]G H Lu, L Y Feng, J X Liu, et al.
Zhonghua Yi Xue Za Zhi|July 30, 2016
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation]M C Lao, L J Liu, C F Luo, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1994
[Pharmacokinetics of matrine in healthy volunteers]P Q Wang, G H Lu, X B Zhou, et al.
International Journal of Peptide and Protein Research|September 1, 1992
Bradykinin and angiotensin II analogs containing a conformationally constrained proline analogP Juvvadi, D J Dooley, C C Humblet, et al.
Chinese Medical Journal|March 1, 1989
The effect of transposition of pedicled omentum to spinal cord ischemia segments. An animal experimentM S Zhan, Q Y Ji, Z Xu, et al.
Journal of Medicinal Chemistry|October 23, 1998
Design of peptidomimetics that inhibit the association of phosphatidylinositol 3-kinase with platelet-derived growth factor-beta receptor and possess cellular activityS R Eaton, W L Cody, A M Doherty, et al.
Molecular Pharmacology|September 1, 1990
Subclasses of angiotensin II binding sites and their functional significanceD T Dudley, R L Panek, T C Major, et al.
Life Sciences|March 6, 1998
Inhibition of FGF-1 receptor tyrosine kinase activity by PD 161570, a new protein-tyrosine kinase inhibitorB L Batley, A M Doherty, J M Hamby, et al.
Journal of Medicinal Chemistry|June 25, 1993
Multiple binding modes for the receptor-bound conformations of cyclic AII agonistsK Plucinska, T Kataoka, M Yodo, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Chinese Medical Journal|September 1, 1994
Smooth muscle tumors of the gastrointestinal tract. Expression of ras P21 oncogene product and the association with clinicopathologyJ H Cai, Y K Jiang, Y Y Zhang, et al.
Zhonghua Yi Xue Za Zhi|February 13, 2026
[Clinical efficacy analysis of globus pallidus internus deep brain stimulation for the treatment of tardive dyskinesia in 5 cases]G H Lu, L Y Feng, J X Liu, et al.
Zhonghua Yi Xue Za Zhi|July 30, 2016
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation]M C Lao, L J Liu, C F Luo, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1994
[Pharmacokinetics of matrine in healthy volunteers]P Q Wang, G H Lu, X B Zhou, et al.
International Journal of Peptide and Protein Research|September 1, 1992
Bradykinin and angiotensin II analogs containing a conformationally constrained proline analogP Juvvadi, D J Dooley, C C Humblet, et al.
Chinese Medical Journal|March 1, 1989
The effect of transposition of pedicled omentum to spinal cord ischemia segments. An animal experimentM S Zhan, Q Y Ji, Z Xu, et al.
Journal of Medicinal Chemistry|October 23, 1998
Design of peptidomimetics that inhibit the association of phosphatidylinositol 3-kinase with platelet-derived growth factor-beta receptor and possess cellular activityS R Eaton, W L Cody, A M Doherty, et al.
Molecular Pharmacology|September 1, 1990
Subclasses of angiotensin II binding sites and their functional significanceD T Dudley, R L Panek, T C Major, et al.
Life Sciences|March 6, 1998
Inhibition of FGF-1 receptor tyrosine kinase activity by PD 161570, a new protein-tyrosine kinase inhibitorB L Batley, A M Doherty, J M Hamby, et al.
Journal of Medicinal Chemistry|June 25, 1993
Multiple binding modes for the receptor-bound conformations of cyclic AII agonistsK Plucinska, T Kataoka, M Yodo, et al.
Pageof 6